These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 27566144

  • 1. Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis.
    Matz EL, Hsieh MH.
    Urology; 2017 Feb; 100():16-19. PubMed ID: 27566144
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL, Sandlund JT, Miser JS, Arasi V, Linehan M, Magrath IT.
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna.
    Morais MM, Belarmino-Filho JN, Brito GA, Ribeiro RA.
    Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257
    [Abstract] [Full Text] [Related]

  • 7. Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
    Ali SA, Danda SK, Basha SA, Rasheed A, Ahmed O, Ahmed MM.
    Indian J Pharmacol; 2014 Oct; 46(1):105-8. PubMed ID: 24550594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
    Dornelas-Filho AF, Pereira VBM, Wong DVT, Nobre LMS, Melo AT, Silva CMS, Wanderley CWS, Nour ML, Araújo LCNC, Silva RO, Pinto FMM, Bingana RD, Souza MHLP, Alencar NMN, Silva PGB, Alves APNN, Almeida PRC, Cunha FQ, Lima-Júnior RCP.
    Int Immunopharmacol; 2018 Sep; 62():96-108. PubMed ID: 29990699
    [Abstract] [Full Text] [Related]

  • 10. Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.
    Yilmaz N, Emmungil H, Gucenmez S, Ozen G, Yildiz F, Balkarli A, Kimyon G, Coskun BN, Dogan I, Pamuk ON, Yasar S, Cetin GY, Yazici A, Ergulu Esmen S, Cagatay Y, Yilmaz S, Cefle A, Sayarlioglu M, Kasifoglu T, Karadag O, Pehlivan Y, Dalkilic E, Kisacik B, Cobankara V, Erken E, Direskeneli H, Aksu K, Yavuz S.
    J Rheumatol; 2015 Sep; 42(9):1661-6. PubMed ID: 26178288
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low-dose cyclophosphamide associated with hemorrhagic cystitis in a breast cancer patient.
    Marshall A, McGrath C, Torigian D, Papanicolaou N, Lal P, Kaplan Tweed C.
    Breast J; 2012 Sep; 18(3):272-5. PubMed ID: 21972971
    [Abstract] [Full Text] [Related]

  • 13. Oral administration of mesna with ifosfamide.
    Goren MP.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):91-6. PubMed ID: 8677457
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats.
    Minhos LF, da Silva de Lima Gehlen AC, Júnior FFB, Dos Santos AC, Souza RIC, de Barros ME.
    Curr Pharm Biotechnol; 2023 Jun; 24(3):438-449. PubMed ID: 35507803
    [Abstract] [Full Text] [Related]

  • 15. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.
    Korkmaz A, Topal T, Oter S.
    Cell Biol Toxicol; 2007 Sep; 23(5):303-12. PubMed ID: 17225077
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the uroprotective efficacy of mesna and HBO treatments in cyclophosphamide-induced hemorrhagic cystitis.
    Etlik O, Tomur A, Deveci S, Pişkin I, Pekcan M.
    J Urol; 1997 Dec; 158(6):2296-9. PubMed ID: 9366379
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.
    Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E.
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):469-73. PubMed ID: 15232716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.